Persistence of pulmonary pathology and abnormal lung function in IL-3/GM-CSF/IL-5 βc receptor-deficient mice despite correction of alveolar proteinosis after BMT

Bone Marrow Transplantation

Volumn 20, Issue 8, 1997, Pages 657-662

  Cooke, K R ^a,e   Nishinakamura, R ^b   Martin, T R ^c   Kobzik, L ^c   Brewer, J ^c   Whitsett, J A ^d   Bungard, D ^a   Murray, R ^b   Ferrara, J L M ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

BMT; Lung; Pathology; PFTs; c deficient

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3 RECEPTOR; INTERLEUKIN 5 RECEPTOR; LUNG SURFACTANT;

AIRWAY CONDUCTANCE; AIRWAY RESISTANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CELL STRUCTURE; CONTROLLED STUDY; LUNG ALVEOLUS PROTEINOSIS; LUNG COMPLIANCE; LUNG DISEASE; LUNG FUNCTION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030725822     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700958     Document Type: Article

References (31)

1. IL3 receptor-deficient mice are normal. Immunity 1995; 2: 211-222.
2. Rosen S, Castleman B, Liebow A. Pulmonary alveolar proteinosis. New Engl J Med 1958; 258: 1123-1142.
3. Moulton S, Krous H, Merritt A et al. Congenital pulmonary alveolar proteinosis: failure of treatment with extracorporeal life support. J Pediatr 1992: 120: 297-302.
4. Schumacher R, Marrogi A, Heidelberger K. Pulmonary alveolar proteinosis in a newborn. Pediatr Pulmonol 1989; 7: 178-182.
5. Wilkson R, Blanc W, Hangstrom J. Pulmonary alveolar proteinosis in three infants. Pediatrics 1968; 41: 510-515.
6. Nishinakamura R, Wiler R, Dirksen U et al. The pulmonary alveolar proteinosis in GM-CSF/IL-5 bc receptor deficient mice is reversed by bone marrow transplantation. J Exp Med 1996; 183: 2657-2662.
7. Martin T, Gerard N, Galli S, Drazen J. Pulmonary responses to bronchoconstrictor agonists in the mouse. J Appl Physiol 1988; 64: 2318-2323.
8. Martin TR, Takeishi T, Katz HR et al. Mast cell activation enhances airway responsiveness to methacholine in the mouse. J Clin Invest 1993; 91: 1176-1182.
9. Lesur O, Veldhuizen R, Whitsett J et al. Surfactant-associated proteins (SP-A, SP-B) are increased proportionally to alveolar phospholipids in sheep silicosis. Lung 1993; 171: 63-74.
10. Pesce M, Strande C. A new method for determination of protein in cerebral spinal fluid and urine. Clin Chem 1974; 19: 265-267.
11. Cooke K, Kobzik L, Martin T et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 1996; 8: 3230-3239.
12. Colon A, Lawrence R, Mills S, O'Connell E. Childhood pulmonary alveolar proteinosis (PAP). Am J Dis Child 1971; 121: 481-485.
13. Davidson J, Macleod W. Pulmonary alveolar proteinosis. Br J Dis Chest 1969; 63: 13-28.
14. Coleman M, Dehner L, Sibley R et al. Pulmonary alveolar proteinosis: an uncommon cause of chronic neonatal respiratory distress. Am Rev Respir Dis 1980; 121: 583-586.
15. Milleron J, Costabel U, Teschler H et al. Bronchoalveolar lavage cell data in alveolar proteinosis. Am Rev Respir Dis 1991; 144: 1330-1332.
16. Claypool W, Rogers R, Matuschak G. Update on the clinical diagnosis, management and pathogenesis of pulmonary alveolar proteinosis. Chest 1984; 85: 550-558.
17. Kao D, Wasserman K, Costley D, Benfield J. Advances in the treatment of pulmonary alveolar proteinosis. Am Rev Respir Dis 1975; 111: 361-363.
18. Camovale R, Zornoza J, Goldman A, Luna M. Pulmonary alveolar proteinosis: its association with hematologic malignancy and lymphoma. Radiol 1977; 122: 303-306.
19. Lakshminarayan S, Schwarz M, Stanford R. Unsuspected pulmonary alveolar proteinosis complicating acute myelogenous leukemia. Chest 1976; 69: 433-435.
20. Lugassy G, Hurwitz M, Oren R et al. Pulmonary alveolar proteinosis associated with recurrence of Hodgkin's disease in the lung. Israel J Med Sci 1990; 26: 446-449.
21. Ruben F, Talamo T. Secondary pulmonary alveolar proteinosis occurring in two patients with acquired immune deficiency syndrome. Am J Med 1986, 80: 1187-1190.
22. Dranoff G, Crawford A, Sadelain M et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 1994; 264: 713-715.
23. Warner T, Balish E. Pulmonary alveolar proteinosis: a spontaneous and inducible disease in immunodeficient germ-free mice. Am J Pathol 1995; 146: 1017-1022.
24. Jennings V, Dillehay D, Webb S, Brown L. Pulmonary alveolar proteinosis in SCID mice. Am J Resp Cell Mol Biol 1995; 13: 297-306.
25. Clark J, Hansen J, Hertz M et al. Idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Respir Dis 1993; 147: 1601-1606.
26. Crawford S, Hackman R. Clinical course of idiopathic pneumonia after bone marrow transplantation. Am Rev Respir Dis 1993; 147: 1393-1400.
27. Crawford S, Longton G, Storb R. Acute graft versus host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia. Bone Marrow Transplant 1993; 12: 225-231.
28. Quabeck K. The lung as a critical organ in marrow transplantation. Bone Marrow Transplant 1994; 14: S19-S28.
29. Milburn H, Du Bois R, Prentice H, Poulter L. Pneumonoitis in bone marrow transplant recipients results from a local immune response. Clin Exp lmmunol 1990; 81: 232-237.
30. Dirksen U, Nishinakamura R, Murray R, Burdach S. Defective GM-CSF/IL-3/IL-5 receptor common β chain expression associated with human pulmonary alveolar proteinosis with or without AML and its correction by hematologic stem cell transplantation (submitted for publication).
31. Cordonnier C, Fleury-Feith J, Escudier E et al. Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients. Am J Resp Crit Care Med 1994; 149: 788-794.